학술논문
Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma
Document Type
Article
Author
Hess, G.; Ohler, A.; Dreyling, M.; Fischer, L.; Oberic, L.; Gine, E.; Zinzani, P.L.; Linton, K.; Vilmar, A.; Jerkeman, M.; Chen, J.M.H.; Keeping, S.; Park, J.E.; Stilgenbauer, S.; Thieblemont, C.; Lambert, J.; Zilioli, V.R.; Sancho, J.-M.; Jimenez-Ubieto, A.; Eyre, T.A.; Wu, J.J.; Nunes, A.; Reitan, J.; Wade, S.W.; Salles, G.
Source
In: Leukemia and Lymphoma . (Leukemia and Lymphoma, 2024, 65(1):14-25)
Subject
Language
English
ISSN
10292403
10428194
10428194